Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
6/1/2021
NMPA Withdraws Approvals of 283 Drug Products Including 12 MNC Product...
5/31/2021
China Announces Three-Child Policy to Alleviate Problem of Ageing Popu...
5/31/2021
China Issues Interim Guideline for the New Patent Law and Clarifies Pa...
5/31/2021
Financial-related Company News in Brief (May 2021)
5/31/2021
Roots Analysis: Chinese Pharma CMO Market Estimated to Reach $13B in 2...
5/31/2021
Sino-Israel Biopharma Fund to Raise $300M for Drug Development JVs
5/31/2021
Sinovac to Set Up A National Vaccine R&D Center As Part of Related BRI...
5/31/2021
AnHeart and Innovent Announce Exclusive License Deal for Taletrectinib...
5/31/2021
Confronted by Demographic Challenges, Will China's Drug Market Prospec...
5/30/2021
Pfizer's Vaccine Gets Caught in the Middle of China-Taiwan Fight
5/28/2021
AffaMed Approved for Phase IIb Trial of AM006 in China for Parkinson's...
5/28/2021
CStone's Sugemalimab Trial Met its Primary Endpoint with Upcoming Ch...
5/28/2021
NMPA Issues the Provisions for Drug Inspection (Interim)
5/28/2021
Recent Executive Moves
5/28/2021
Review of Chinese Innovative Drug Research Failures
5/28/2021
NHC: Health Statistics on Chinese Medical Care Providers and Patient V...
5/26/2021
Sinovant and Nabriva Announce Positive Topline Results from Phase 3 T...
5/26/2021
Shanghai Introduces New Policy to Enhance Development of Biopharma In...
5/26/2021
AZ to Market Boan Biotech's Boyounuo (Bevacizumab Inj.) in Specific ...
5/26/2021
Roche and TransTherato Evaluate Atezolizumab/TT-00420 Combo for GI Ca...
5/25/2021
China and EU Held Pharmaceutical Regulatory Dialogue over Video Confer...
5/25/2021
China Drug Patent Registration System (Orange Book) Opened For Testing
5/25/2021
Patent Term Extension Introduced by the Fourth Amendment to the Chines...
5/24/2021
Nicholas Hall Reports Slower Chinese CHC and OTC GI Market Growth in 2...
5/24/2021
PPD Opens Clinical Research Lab in Suzhou
5/24/2021
BeiGene, Novartis Report Promising Topline Results of Tislelizumab ...
5/24/2021
Akeso Submits BLA for Penpulimab mAb in the U.S.
5/21/2021
Everest Med Granted Priority Review for Sacituzumab Govitecan-hziy in ...
5/21/2021
CARsgen Plans $157M Cancer Cell Therapy Facility in North Carolina
5/21/2021
US Professor with China Ties Jailed for Lying on Grant Applications
Page:
185
/
774
Total number of articles:
23219
:
[First]
[<<]
[183]
[184]
[185]
[186]
[187]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit